Recruitment

Recruitment for this trial has been completed. Thank you.

About PIPSICKLE Trial

PIPSICKLE:
Low dose aspirin for preventing intrauterine growth restriction and preeclampsia in sickle cell pregnancy.

This will be the first randomized control trial to be performed in pregnant women with sickle cell disease in Nigeria.

The researchers include a skilled team of investigators, site coordinators, and other health professionals across selected study sites in Nigeria.

Principal Investigator

Prof. Bosede B. Afolabi (MBChB, DM(Notts),
FRCOG (UK), FWACS, FMCOG)
Department of Obstetrics & Gynaecology
College of Medicine, University of Lagos/Idi-Araba, Lagos.